Federal Prosecutor Questions Medical Journals Over Alleged Bias
By I. Edwards HealthDay Reporter
WEDNESDAY, April 23, 2025 (HealthDay News) — At least three medical journals have received letters from a top federal prosecutor...
CDC Shuts Down Key Labs for Hepatitis and STI Testing After Layoffs
By I. Edwards HealthDay Reporter
MONDAY, April 21, 2025 (HealthDay News) — Key labs at the U.S. Centers for Disease Control and Prevention (CDC) have...
Gastrointestinal Disease Tied to High Physical, Financial Burden
One in six adults report having one or more frequent GI symptoms in the past three months
Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer
Lower odds of receiving key components of quality care seen for those with high overall social vulnerability index
CT Exams in 2023 Projected to Result in 103,000 Future Cancers
Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers
New Trial Will Test Gene-Edited Pig Liver for Sudden Liver Failure Patients
By I. Edwards HealthDay Reporter
WEDNESDAY, April 16, 2025 (HealthDay News) -- A new clinical trial will soon test if a pig liver can help...
Breast, Colorectal Cancer Screening Higher Than Lung Cancer Screening
Among individuals eligible for lung cancer screening, use of BCS and CCS is much higher than use of LCS
Adverse Events From Semaglutide Seen in the ED Usually GI-Related
Most common gastrointestinal issues seen are nausea/vomiting, abdominal pain, and diarrhea
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury
By I. Edwards HealthDay Reporter
TUESDAY, April 15, 2025 (HealthDay News) -- Pfizer has stopped developing a once-daily pill to treat obesity after a person...
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib
